Keyphrases
Graft-versus-host Disease (GvHD)
100%
Life-threatening
100%
Human Chorionic Gonadotropin
100%
Epidermal Growth Factor
100%
Immunosuppression
33%
High-risk Population
33%
High Risk
33%
Immune Regulation
33%
Minnesota
16%
Immunomodulation
16%
Immune Response
16%
Dose-limiting Toxicity
16%
Regulatory T Cells
16%
Blood Test
16%
Phase 1 Study
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Second-line Therapy
16%
Initial Treatment
16%
Supportive Care
16%
Hormone Response
16%
Subcutaneous Injection
16%
Disease Activity
16%
Supportive Therapy
16%
Complete Response
16%
Cell Ratio
16%
Butyrate
16%
High-dose Steroids
16%
Amphiregulin
16%
Fatal Complication
16%
Mucosal Damage
16%
Epithelial Repair
16%
Conventional T Cells
16%
Medicine and Dentistry
Chorionic Gonadotropin
100%
Graft Versus Host Reaction
100%
Epidermal Growth Factor
100%
Urinary System
83%
Acute Graft Versus Host Disease
83%
Immunomodulation
50%
Immunosuppressive Treatment
33%
Biological Marker
16%
T Cell
16%
Drug Megadose
16%
Supplementation
16%
Hematopoietic Cell
16%
Cell Transplantation
16%
Regulatory T Cell
16%
Supportive Care
16%
Subcutaneous Injection
16%
Butyric Acid
16%
Disease Activity
16%
Amphiregulin
16%
Hormone Response
16%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Acute Graft Versus Host Disease
100%
Epidermal Growth Factor
100%
Blood Plasma
80%
Immunomodulation
60%
Immunosuppression
40%
Regulatory T Cell
20%
Cell Transplantation
20%
Drug Megadose
20%
Amphiregulin
20%
Hormone Response
20%
T Cell
20%
Hematopoietic Cell
20%